Life
Clonal Hematopoiesis Associates with Idiopathic Pulmonary Fibrosis
Clonal hemotopoiesis is the emergence of patterns of potentially problematic mutations occurring in hematopoietic stem c…
Life
441 articles
Life
STAT+: Abivax has still not been acquired. What’s going on?
Biotech M&A activity is off the charts, yet the French drugmaker Abivax hasn't been picked up yet. There may be som…
Life
Life Biosciences Begins First Human-Age-Reversal Gene Therapy Trial - 조선일보
Life Biosciences Begins First Human-Age-Reversal Gene Therapy Trial 조선일보…
Life
Russia's Putin is spending $26 billion to live forever - startupfortune.com
Russia's Putin is spending $26 billion to live forever startupfortune.com…
Life
STAT+: FDA pilot offers generative AI medical devices a path to patients before they are authorized
AI products from Cadence and Limbic are among four devices recently accepted into the FDA’s TEMPO pilot that will allow …
Life
Opinion: STAT+: A surprising bright spot at the FDA on regulating unproven stem cells
“These successes are surprising, worth discussing, and even celebrating a bit,” STAT Lab Dish columnist Paul Knoepfler w…
Life
Exclusive Survey Shows What Americans Would Give Up for a Longer Life - National Geographic
Exclusive Survey Shows What Americans Would Give Up for a Longer Life National Geographic…
Life
Is a key to longevity sitting in your medicine cabinet? - Northeastern Global News
Is a key to longevity sitting in your medicine cabinet? Northeastern Global News…
Life
Stem Cell Conference Dubai: Exploring the Future of Regenerative Medicine - Business Post Nigeria
Stem Cell Conference Dubai: Exploring the Future of Regenerative Medicine Business Post Nigeria…
Life
David Sinclair Launches Lifespan Media Platform for Longevity Science - The Clinical Trial Vanguard
David Sinclair Launches Lifespan Media Platform for Longevity Science The Clinical Trial Vanguard…
Life
Why are drug overdose deaths declining?
Naloxone and harm reduction measures may be helping to curb drug overdose deaths, a new report says.…
Life
Lifespan-extending treatments increase variation in age at time of death - Medical Xpress
Lifespan-extending treatments increase variation in age at time of death Medical Xpress…
Life
AgelessRx 2026: Every Treatment, Real Pricing, and What to Evaluate Before Your First Longevity Telehealth Visit - Newswire.com
AgelessRx 2026: Every Treatment, Real Pricing, and What to Evaluate Before Your First Longevity Telehealth Visit &n…
Life
The science – and truth – about anti-ageing pills: Are they real and do they actually work? - Mamabella
The science – and truth – about anti-ageing pills: Are they real and do they actually work? Mamabella…
Life
STAT+: Ultragenyx drug to treat Angelman syndrome, a rare disease, fails late-stage trial
Ultragenyx said its experimental therapy for Angelman syndrome, a rare disease, showed no benefit compared to a sham tre…
Life
「Longevity Global Conference」、世界のトップリーダー30名以上が大阪に集結「Next - news.nicovideo.jp
「Longevity Global Conference」、世界のトップリーダー30名以上が大阪に集結「Next news.nicovideo.jp…
Life
Understanding Metformin Price and Its Market Dynamics - OCNJ Daily
Understanding Metformin Price and Its Market Dynamics OCNJ Daily…
Life
Senescent Cells in Metabolic Disorders
The most common metabolic diseases, such as type 2 diabetes or fatty liver disease leading to metabolic dysfunction-asso…
Life
Invested in Her Campaign Extends Fundraising Deadline
Driven by ongoing support from their community, The Longevity Science Foundation is extending the deadline for the Inves…
Life
科学家称人类寿命最高“上限”为115岁 - language.chinadaily.com.cn
科学家称人类寿命最高“上限”为115岁 language.chinadaily.com.cn…
Life
Doctors groups release vaccination guidelines ahead of respiratory illness season
Ahead of respiratory illness season, professional organizations have issued guidance on flu, Covid, and RSV vaccines.…
Life
STAT+: ARPA-H funds biotechs working on custom RNA therapies
Roche licenses a tri-specific antibody, new Trump deals may undercut its own goals, and other biotech news…
Life
STAT+: How a former ARPA-H director’s startup is tackling AI’s ‘dumb problems’
In this edition of STAT's AI Prognosis: A startup tackling the 'dumb problems' at the intersection of AI and bio, accura…
Life
STAT+: Pharmalittle: We’re reading about a Huntington’s gene therapy, Novo’s challenges, and more
UniQure has submitted its Huntington’s gene therapy to the FDA, investors remain unenthusiastic on Novo Nordisk, and mor…